Watch Ticker

Rallybio Corporation Common Stock

Go to Rallybio Corporation Common Stock Website

$0.53

-0.01 (-0.93%)

Live

Previous Close

$0.529

Day Range

$0.5208 - $0.57829

Previous Day Range

$0.43 - $0.555

Market Cap

$22.3 million USD

Day Vol.

710894

Previous Day Vol.

925860

Currency

USD

Primary Exchange

Nasdaq

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Lee Samaha - Here's Why Shares in Recursion Pharmaceuticals Surged Today

Recursion Pharmaceuticals acquired full ownership of REV102, an ENPP1 inhibitor program for treating hypophosphatasia, from Rallybio, reducing pipeline uncertainty and potentially adding value to its drug development efforts.

Related tickers: RXRX, RLYB.

Read Full Article

Vandana Singh - Why Is Microcap Rallybio Stock Trading Higher On Tuesday?

Rallybio Corporation sold its interest in REV102, a preclinical ENPP1 inhibitor for hypophosphatasia, to Recursion Pharmaceuticals for up to $25 million, extending its cash runway into mid-2027.

Related tickers: RLYB, RXRX.

Read Full Article

Trending Tickers

Please sign in to view